Filgrastim, sold under the brand name Neupogen among others, is a medication used to treat low neutrophil count. Low neutrophil counts may occur with HIV/AIDS...
23 KB (1,645 words) - 05:49, 26 March 2024
tissues. The pharmaceutical analogs of naturally occurring G-CSF are called filgrastim and lenograstim. G-CSF also stimulates the survival, proliferation, differentiation...
27 KB (3,223 words) - 15:10, 21 February 2024
the United States' first biosimilar product, the biosimilar of filgrastim called filgrastim-sndz (trade name Zarxio) by Sandoz. In the United States, the...
95 KB (6,480 words) - 22:51, 13 May 2024
recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils)...
15 KB (844 words) - 18:08, 21 March 2024
December 2006, to seek approval for a clinical trial of its biosimilar Filgrastim in Europe and was certified as EU-GMP compliant in April 2007, becoming...
14 KB (1,116 words) - 03:45, 29 May 2024
Apotex (section Launch of biosimilar filgrastim)
way to boost white blood count. Apotex's version is known as Grastofil (filgrastim) and is licensed for sale in Europe by Stada Arzneimittel. In February...
33 KB (3,410 words) - 14:01, 21 August 2023
April 2019). "Neupogen, Granix, Zarxio, Nivestym (filgrastim, tbo-filgrastim, filgrastim-sndz, filgrastim-aafi, G-CSF) dosing, indications, interactions...
6 KB (515 words) - 17:22, 27 September 2023
long-term use of filgrastim causing sequestration of platelets in the spleen in GSD Ib, anemia, due to long-term use of filgrastim causing sequestration...
45 KB (5,801 words) - 07:01, 15 April 2024
occurring glycoproteins that stimulate white blood cell proliferation. Filgrastim is a synthetic form of GCSF produced in E.coli. PBSC donors are given...
9 KB (939 words) - 08:49, 3 December 2023
guidelines. Company has developed biosimilar versions of Etanercept, Filgrastim, Peg-filgrastim, Ranibizumab. Lupin forayed into diagnostics business in December...
23 KB (2,108 words) - 01:45, 29 May 2024
against rheumatoid arthritis, ankylosing spondylitis, and COVID-19. CFU-GM Filgrastim (Neupogen, a granulocyte colony-stimulating factor (G-CSF) analog)...
17 KB (1,672 words) - 11:59, 30 August 2023
factor used (G-CSF). G-CSF drugs include filgrastim (Neupogen, Neulasta), and lenograstim (Graslopin). Filgrastim is typically dosed in the 10 microgram/kg...
70 KB (7,848 words) - 14:09, 10 May 2024
fidexaban (USAN) figitumumab (USAN, INN) filaminast (INN) filenadol (INN) filgrastim (INN) filibuvir (USAN, INN) filipin (INN) Filspari Filsuvez fimasartan...
2 KB (183 words) - 06:23, 1 June 2024
SCN respond to treatment with granulocyte colony-stimulating factor (filgrastim), which increases the neutrophil count and decreases the severity and...
20 KB (1,976 words) - 22:07, 2 December 2023
States in September 2023. Motixafortide is indicated, in combination with filgrastim, a granulocyte-colony stimulating factor (G-CSF), to mobilize hematopoietic...
9 KB (546 words) - 05:18, 14 March 2024
receiving chemotherapy. Lipegfilgrastim is a filgrastim biosimilar. In lipegfilgrastim, the filgrastim has been 'pegylated' (attached to polyethylene...
7 KB (435 words) - 00:21, 15 March 2024
(neutropenia) can cause complications, and is sometimes treated with drugs like filgrastim. The most notable complication of neutropenia is increased probability...
15 KB (1,438 words) - 02:57, 10 May 2024
comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced...
8 KB (831 words) - 04:05, 28 February 2024
has obtained a marketing authorization in 2016 for the biosimilar of Filgrastim, marketed under Fraven, which is the first biosimilar drug, developed...
10 KB (1,172 words) - 17:11, 5 April 2024
Announces FDA Approval of Aphexda (motixafortide) in Combination with Filgrastim (G-CSF) to Mobilize Hematopoietic Stem Cells for Collection and Subsequent...
127 KB (13,052 words) - 10:10, 8 May 2024
CSF3 – Granulocyte colony-stimulating factors (also called G-CSF and filgrastim) Interleukin 3 Synthetic – Promegapoietin Bone marrow stimulation Stem...
3 KB (374 words) - 18:45, 17 July 2023
PMID 17209059. Saven A, Burian C, Adusumalli J, Koziol JA (April 1999). "Filgrastim for cladribine-induced neutropenic fever in patients with hairy cell leukemia"...
81 KB (7,943 words) - 00:48, 30 May 2024
(CERA/Mircera) Peginesatide Pegol sihematide (EPO-018B) G-CSF (CSF3) Agonists: Filgrastim Granulocyte colony-stimulating factor Lenograstim Leridistim Lipegfilgrastim...
31 KB (2,617 words) - 15:26, 6 April 2024
(CERA/Mircera) Peginesatide Pegol sihematide (EPO-018B) G-CSF (CSF3) Agonists: Filgrastim Granulocyte colony-stimulating factor Lenograstim Leridistim Lipegfilgrastim...
62 KB (7,054 words) - 14:45, 30 May 2024
(CERA/Mircera) Peginesatide Pegol sihematide (EPO-018B) G-CSF (CSF3) Agonists: Filgrastim Granulocyte colony-stimulating factor Lenograstim Leridistim Lipegfilgrastim...
26 KB (2,160 words) - 09:06, 23 May 2024
kill the hairy cells. People with low neutrophil counts may be given filgrastim or a similar hormone to stimulate production of white blood cells. However...
57 KB (7,246 words) - 15:29, 13 May 2024
responds well to treatment with granulocyte colony-stimulating factor (filgrastim), which increases the neutrophil count, shortens the cycle length, as...
23 KB (2,435 words) - 11:25, 3 June 2024
improved with synthetic G-CSF (granulocyte-colony-stimulating factor, e.g., filgrastim, lenograstim, efbemalenograstim alfa). In very severe myelosuppression...
154 KB (17,494 words) - 04:15, 13 March 2024
(CERA/Mircera) Peginesatide Pegol sihematide (EPO-018B) G-CSF (CSF3) Agonists: Filgrastim Granulocyte colony-stimulating factor Lenograstim Leridistim Lipegfilgrastim...
31 KB (3,413 words) - 22:16, 21 March 2024
colony-stimulating factor (G-CSF), leading to the development of Neupogen (filgrastim). In October 1988, Gordon Binder was named CEO, succeeding George Rathmann...
97 KB (7,882 words) - 18:47, 29 May 2024